COVID-19 Vaccine Global Access (COVAX) initiative
GPTKB entity
Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:initiative
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:WHO
|
| gptkbp:addressed |
global health disparities
vaccine supply chain issues |
| gptkbp:addresses |
vaccine distribution challenges
|
| gptkbp:aims_to |
ensure equitable access to COVID-19 vaccines
reduce vaccine hesitancy support vaccine research and development increase vaccine manufacturing capacity |
| gptkbp:collaborated_with |
gptkb:football_match
gptkb:governments research institutions |
| gptkbp:collaborates_with |
pharmaceutical companies
|
| gptkbp:developer |
non-governmental organizations (NG Os)
|
| gptkbp:engages_in |
local communities
|
| gptkbp:facilitates |
vaccine trials
|
| gptkbp:focuses_on |
vulnerable populations
healthcare workers |
| gptkbp:has_goal |
end the acute phase of the pandemic
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 Vaccine Global Access (COVAX) initiative
|
| gptkbp:involves |
gptkb:GAVI,_the_Vaccine_Alliance
gptkb:Coalition_for_Epidemic_Preparedness_Innovations_(CEPI) |
| gptkbp:is_aimed_at |
reducing transmission of COVID-19
|
| gptkbp:is_criticized_for |
slow vaccine rollout
|
| gptkbp:is_designed_to |
facilitate vaccine access
|
| gptkbp:is_evaluated_by |
gptkb:WHO
independent experts vaccine effectiveness |
| gptkbp:is_informed_by |
gptkb:Research_Institute
|
| gptkbp:is_involved_in |
vaccine procurement
|
| gptkbp:is_linked_to |
global health security
|
| gptkbp:is_monitored_by |
vaccine distribution progress
|
| gptkbp:is_part_of |
global vaccination efforts
global health response to COVID-19 |
| gptkbp:is_promoted_by |
health advocates
|
| gptkbp:is_supported_by |
gptkb:treaty
government funding private sector partners philanthropic foundations |
| gptkbp:launched |
gptkb:2020
gptkb:World_Health_Organization_(WHO) |
| gptkbp:operates_under |
gptkb:Access_to_COVID-19_Tools_(ACT)_Accelerator
|
| gptkbp:partnership |
gptkb:GAVI,_the_Vaccine_Alliance
|
| gptkbp:promotes |
vaccine equity
public health measures vaccine literacy |
| gptkbp:provides |
vaccines to low-and middle-income countries
|
| gptkbp:receives |
support from international organizations
|
| gptkbp:receives_funding_from |
donor countries
|
| gptkbp:reports_to |
vaccine safety
by global health organizations |
| gptkbp:supports |
vaccine innovation
|
| gptkbp:targets |
2 billion vaccine doses by the end of 2021
|